Built to provide research that’s more actionable and strategically valuable, The Business Research Company’s 2026 market reports include market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, broader supply chain intelligence, emerging startup tracking, and in-depth product insights.
#Particle Therapy Market Growth Analysis: How Will Revenue Trend Over The Forecast Period?#_x000D_
The particle therapy market size has seen rapid growth in recent years. It is anticipated to expand from $1.36 billion in 2025 to $1.53 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.1%. The expansion observed in the past can be credited to rising cancer incidence rates, the early adoption of proton therapy technologies, the establishment of more specialized oncology centers, growing clinical evidence supporting particle therapy, and investments made by academic research hospitals._x000D_
_x000D_
The particle therapy market is projected to experience substantial expansion in the coming years, with its size forecast to reach $2.44 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 12.4%. Factors contributing to this growth during the forecast period include the broader implementation of personalized cancer therapies, increased investment in sophisticated oncology treatments, a heightened need for accurate radiation therapies, continuous innovation in accelerator technologies, and the increasing uptake in developing healthcare sectors. Key trends anticipated within this period involve the wider acceptance of pencil beam scanning systems, the increasing establishment of single-room particle therapy facilities, the expanding application of carbon ion therapy, advancements in precise treatment planning tools, and a sharpened emphasis on oncological care for children._x000D_
_x000D_
#Get A Free Sample Report With In-Depth Market Insights:#_x000D_
_x000D_
#Particle Therapy Market Demand Drivers: What’s Powering Industry Growth?#_x000D_
The increasing prevalence of cancer is projected to drive the expansion of the particle therapy market. Cancer is defined as a diverse group of diseases characterized by the abnormal proliferation and growth of cells within the body. Particle therapy offers a precise and effective method for treating cancer through radiation, where positively charged particles (protons) are accelerated to high speeds and accurately targeted at tumors. For example, data released in April 2024 by the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, indicated that in 2022, nearly 20 million new cancer cases were reported globally, resulting in almost 10 million deaths due to the disease. Projections based on demographic trends further suggest that the annual number of new cancer cases could escalate to 35 million by 2050, which represents a 77% increase from the 2022 figures. This growing prevalence of cancer is therefore a key driver for the particle therapy market’s growth._x000D_
_x000D_
#Particle Therapy Market Segment Analysis And Revenue Potential#_x000D_
The particle therapy market covered in this report is segmented – _x000D_
_x000D_
1) By Type: Proton Therapy, Heavy Ion Therapy_x000D_
2) By System: Single-Room Systems, Multi-Room Systems_x000D_
3) By Cancer Type: Pediatric Cancer, Prostate Cancer, Lung Cancer, Brain And Spinal Cord Cancer, Other Cancer Types_x000D_
4) By End-User: Hospital, Academic And Research Centers_x000D_
_x000D_
Subsegments:_x000D_
1) By Proton Therapy: Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT) _x000D_
2) By Heavy Ion Therapy: Carbon Ion Therapy, Helium Ion Therapy_x000D_
_x000D_
#Particle Therapy Market Innovation Trends: What Developments Are Reshaping The Industry?#_x000D_
Leading companies in the particle therapy sector are increasingly focusing on developing innovative therapies, such as the proton therapy solution, to gain a competitive edge. Proton therapy technology is an advanced form of cancer treatment that utilizes protons, which are positively charged particles, to deliver precise and targeted radiation to cancer cells. For example, in April 2023, P-Cure, an Israel-based high-med-tech company, received clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing sales in the USA. This solution provides an affordable proton therapy technology for the targeted treatment of cancer, significantly reducing treatment-related side effects. P-Cure’s innovative upright solution is also the world’s first FDA-approved methodology for patient positioning, allowing patients to be treated while seated, which enhances both patient comfort and clinical results._x000D_
_x000D_
#Particle Therapy Market Competitive Analysis Of Leading Industry Participants#_x000D_
Major companies operating in the particle therapy market are Hitachi Ltd., Mitsubishi Electric Corporation, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., IBA Worldwide, Mevion Medical Systems Inc., ProNova Solutions LLC, Advanced Oncotherapy plc, Shinva Medical Instrument Co. Ltd., Optivus Proton Therapy Inc., Protom International Inc., Danfysik AS, Toshiba Energy Systems And Solutions Corporation, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Elekta AB, Accuray Incorporated, Xstrahl Inc. _x000D_
_x000D_
#View The Full Particle Therapy Market Report:#_x000D_
_x000D_
#Particle Therapy Market Geographic Spread And Regional Opportunities#_x000D_
North America was the largest region in the particle therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
#Reach Out To Our Team:#_x000D_
_x000D_
The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_
Americas: +1 310-496-7795_x000D_
Asia: +44 7882 955267 & +91 8897263534_x000D_
Europe: +44 7882 955267_x000D_
Email us at: marketing@tbrc.info_x000D_
_x000D_
#Follow us on:#_x000D_
_x000D_
LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.